LifePoint Health (NASDAQ:LPNT) announced its quarterly earnings data on Friday. The company reported $0.77 earnings per share for the quarter, missing analysts’ consensus estimates of $0.81 by ($0.04), Bloomberg Earnings reports. LifePoint Health had a net margin of 2.45% and a return on equity of 7.01%. The company had revenue of $1.49 billion for the quarter, compared to the consensus estimate of $1.58 billion. During the same quarter in the previous year, the business earned $1.07 EPS. The company’s quarterly revenue was down 7.2% compared to the same quarter last year. LifePoint Health updated its FY18 guidance to $4.00-4.53 EPS.
Shares of LifePoint Health (LPNT) opened at $42.75 on Friday. LifePoint Health has a twelve month low of $41.45 and a twelve month high of $67.95. The company has a debt-to-equity ratio of 1.24, a current ratio of 1.85 and a quick ratio of 1.65. The company has a market cap of $1,685.03, a PE ratio of 17.38, a PEG ratio of 0.98 and a beta of 0.52.
In other news, Director Marguerite Kondracke sold 3,907 shares of the business’s stock in a transaction dated Tuesday, November 28th. The shares were sold at an average price of $44.73, for a total value of $174,760.11. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider David M. Dill sold 45,000 shares of the business’s stock in a transaction dated Tuesday, January 16th. The shares were sold at an average price of $48.52, for a total transaction of $2,183,400.00. Following the completion of the sale, the insider now owns 252,673 shares of the company’s stock, valued at approximately $12,259,693.96. The disclosure for this sale can be found here. Insiders own 8.76% of the company’s stock.
Large investors have recently bought and sold shares of the company. Cerebellum GP LLC bought a new stake in shares of LifePoint Health in the 4th quarter valued at about $126,000. State of Alaska Department of Revenue purchased a new position in shares of LifePoint Health in the 4th quarter worth approximately $134,000. US Bancorp DE grew its position in shares of LifePoint Health by 62.4% in the 4th quarter. US Bancorp DE now owns 3,095 shares of the company’s stock worth $155,000 after buying an additional 1,189 shares during the last quarter. Xact Kapitalforvaltning AB purchased a new position in shares of LifePoint Health in the 4th quarter worth approximately $230,000. Finally, Parametrica Management Ltd purchased a new position in shares of LifePoint Health in the 3rd quarter worth approximately $282,000.
LPNT has been the subject of a number of research analyst reports. Goldman Sachs Group initiated coverage on shares of LifePoint Health in a report on Wednesday, January 3rd. They set a “sell” rating and a $45.00 price objective for the company. KeyCorp reiterated a “hold” rating on shares of LifePoint Health in a report on Sunday, October 29th. SunTrust Banks set a $54.00 price objective on shares of LifePoint Health and gave the company a “hold” rating in a report on Tuesday, October 31st. Citigroup decreased their price objective on shares of LifePoint Health from $70.00 to $60.00 and set a “buy” rating for the company in a report on Monday, October 30th. Finally, Zacks Investment Research upgraded shares of LifePoint Health from a “strong sell” rating to a “hold” rating in a report on Monday, January 22nd. One research analyst has rated the stock with a sell rating, fifteen have assigned a hold rating and five have assigned a buy rating to the stock. The company currently has a consensus rating of “Hold” and an average price target of $58.13.
About LifePoint Health
LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. As of December 31, 2016, the Company operated 72 hospital campuses in 22 states, having a total of 9,424 licensed beds. It offers a range of general and specialized healthcare services to patients through a network of hospitals and outpatient facilities.
Receive News & Ratings for LifePoint Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Health and related companies with MarketBeat.com's FREE daily email newsletter.